GOLDMAN SACHS GROUP INC - AVALO THERAPEUTICS INC ownership

AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F207. A total of 33 filers reported holding AVALO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AVALO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$56,457
-66.2%
32,261
-2.6%
0.00%
Q4 2022$166,868
+41.4%
33,108
-7.1%
0.00%
Q3 2022$118,00035,6440.00%
Other shareholders
AVALO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 185,345$220.00%
Baader Bank Aktiengesellschaft 184,373$19,8230.00%
VANGUARD GROUP INC 91,817$11,0820.00%
First Horizon Advisors, Inc. 276$330.00%
JANE STREET GROUP, LLC 27,482$3,3170.00%
UBS Group AG 112$140.00%
OSAIC HOLDINGS, INC. 347$420.00%
FIFTH THIRD BANCORP 279$340.00%
Parallel Advisors, LLC 1$00.00%
WELLS FARGO & COMPANY/MN 1,241$1500.00%
View complete list of AVALO THERAPEUTICS INC shareholders